Dr. Arthur C. Lee, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- Icahn School of Medicine at Mount Sinai (1997)
- Years since graduation
- 29
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,333
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1997Medical school: Icahn School of Medicine at Mount Sinai
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
FL license ME90119 -
Cardiovascular Disease Physician
FL license ME90119
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Uf Health Shands Hospital Gainesville, FL
- HCA Florida North Florida Hospital Gainesville, FL
- HCA Florida Lake City Hospital Lake City, FL
- Providence St Mary Medical Center Walla Walla, WA
Medical groups
- Interventional Cardiologists of Gainesville, PA (36 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,333
- Services billed
- 5,893
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 1,371 | 24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 802 | 691 |
| Established patient office or other outpatient visit, 30-39 minutes | 782 | 644 |
| Injection, regadenoson, 0.1 mg | 408 | 102 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 227 | 226 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 168 | 84 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 153 | 152 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 143 | 132 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 142 | 93 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 139 | 49 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Xarelto (rivaroxaban) Other prescribers in Gainesville, FL | 293 |
| Atorvastatin Calcium Other prescribers in Gainesville, FL | 275 |
| Eliquis (apixaban) Other prescribers in Gainesville, FL | 254 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Gainesville, FL | 251 |
| Metoprolol Succinate Other prescribers in Gainesville, FL | 239 |
| Jardiance (empagliflozin) Other prescribers in Gainesville, FL | 207 |
| Rosuvastatin Calcium Other prescribers in Gainesville, FL | 200 |
| Furosemide Other prescribers in Gainesville, FL | 186 |
| Entresto (sacubitril/valsartan) Other prescribers in Gainesville, FL | 185 |
| Amlodipine Besylate Other prescribers in Gainesville, FL | 151 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 29 companies reported 150 payments worth $73,137 in total to this clinician.
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14,382 |
|---|---|
| Bard Peripheral Vascular, Inc. | $13,655 |
| Angiodynamics, Inc. | $12,943 |
| Lilly USA, LLC | $12,530 |
| Amgen Inc. | $10,798 |
| Cook Incorporated | $3,425 |
| Inari Medical, Inc. | $1,848 |
| Cook Medical LLC | $1,051 |
| Compensation for services other than consulting (speaking, faculty) | $40,712 |
|---|---|
| Consulting Fee | $21,365 |
| Food and Beverage | $5,863 |
| Travel and Lodging | $4,736 |
| Long term medical supply or device loan | $460 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Bard Peripheral Vascular, Inc. Jan 9, 2025 | Consulting Fee | $13,225 |
| Angiodynamics, Inc. Apr 18, 2025 | Consulting Fee AURYON LASER SYSTEM 100-120 VAC · PAD | $7,007 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 7, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $4,175 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Oct 28, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $4,175 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 3, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $4,175 |
| Cook Incorporated Dec 2, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,425 |
| Amgen Inc. Sep 22, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $3,000 |
| Amgen Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $3,000 |
| Amgen Inc. Oct 1, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $3,000 |
| Lilly USA, LLC Feb 24, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $2,280 |
All 30 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 15, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,520 |
| Stryker Corporation Dec 12, 2025 | Travel and Lodging CT THROMBECTOMY SYSTEM KIT · INARI MEDICAL · travel to TALLAHASSEE, FL | $179 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 3, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $4,175 |
| Cook Incorporated Dec 2, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,425 |
| Lilly USA, LLC Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,520 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Oct 28, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $4,175 |
| Amgen Inc. Oct 1, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $3,000 |
| Amgen Inc. Oct 1, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $500 |
| Lilly USA, LLC Sep 26, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,520 |
| Amgen Inc. Sep 26, 2025 | Travel and Lodging REPATHA · Cardiovascular · travel to Tallahassee, FL · in-kind | $166 |
| Amgen Inc. Sep 26, 2025 | Travel and Lodging REPATHA · Cardiovascular · travel to Tallahassee, FL · in-kind | $20.00 |
| Amgen Inc. Sep 22, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $3,000 |
| Lilly USA, LLC Sep 19, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,520 |
| Lilly USA, LLC Sep 18, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,520 |
| Lilly USA, LLC Sep 11, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,520 |
| Lilly USA, LLC Aug 29, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,520 |
| Lilly USA, LLC Aug 29, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,130 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 7, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $4,175 |
| Angiodynamics, Inc. May 2, 2025 | Travel and Lodging AURYON LASER SYSTEM 100-120 VAC · PAD · travel to BARCELONA, Spain | $1,801 |
| Angiodynamics, Inc. May 2, 2025 | Consulting Fee AURYON LASER SYSTEM 100-120 VAC · PAD | $1,133 |
| Angiodynamics, Inc. Apr 18, 2025 | Consulting Fee AURYON LASER SYSTEM 100-120 VAC · PAD | $7,007 |
| Angiodynamics, Inc. Apr 18, 2025 | Compensation for services other than consulting (speaking, faculty) AURYON LASER SYSTEM 100-120 VAC · PAD | $462 |
| Amgen Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $3,000 |
| Amgen Inc. Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $750 |
| Angiodynamics, Inc. Mar 10, 2025 | Long term medical supply or device loan VenaCure 1470 Pro · ID · in-kind | $460 |
| Lilly USA, LLC Feb 24, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $2,280 |
| Angiodynamics, Inc. Feb 1, 2025 | Travel and Lodging ANGIOVAC · VIT · travel to FORT LAUDERDALE, FL · in-kind | $1,166 |
| Inari Medical, Inc. Jan 24, 2025 | Travel and Lodging FLOWTRIEVER CATHETER, S; CT THROMBECTOMY SYSTEM KIT · VTE · travel to IRVINE, CA · in-kind | $178 |
| Inari Medical, Inc. Jan 15, 2025 | Travel and Lodging CT THROMBECTOMY SYSTEM KIT; FLOWTRIEVER CATHETER, S · VTE · travel to IRVINE, CA · in-kind | $1,227 |
| Bard Peripheral Vascular, Inc. Jan 9, 2025 | Consulting Fee | $13,225 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $5,265 in research payments for these studies, mostly to the institutions running them.
- Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
Abbott Laboratories · Active, not recruiting · NCT03108456
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.